Not all weight loss injections are created equal. Ozempic®, Wegovy®, Mounjaro®, and Zepbound™ each work differently, have different FDA-approved uses, and produce different results. At Richmond Aesthetic Weight Loss, we offer all four and work with you to match the right medication to your health history, goals, and lifestyle, because the best injection is the one that’s right for you specifically.
If you’ve been paying attention to the conversation around medical weight loss, you’ve probably heard the names Ozempic®, Wegovy®, Mounjaro®, and Zepbound™ tossed around as though they’re interchangeable. While they all belong to the same class of medications and share some similarities, there are meaningful differences between them that matter when it comes to which one belongs in your weight loss plan. Here’s what you need to know.
Two Drugs, Four Brand Names
The first thing that clears up a lot of confusion: these four medications actually represent just two distinct active ingredients.
Ozempic® and Wegovy® both contain semaglutide, while Mounjaro® and Zepbound™ both contain tirzepatide. Think of it this way: you have two compounds, each sold under two different brand names depending on what they’re being prescribed for. That distinction matters more than most people realize.
How They Work
Both semaglutide and tirzepatide work by acting like hormones your body normally makes after you eat. They can make your stomach empty more slowly so that you won’t want to eat again as soon. They also send signals to the brain that tell you you’re full.
The key difference is in how many hormones they mimic. Tirzepatide mimics two hormones while semaglutide mimics one. Specifically, Mounjaro® and Zepbound™ activate the GIP pathway in addition to GLP-1, which can enhance insulin secretion and further reduce appetite. This dual-action approach is one reason tirzepatide-based medications tend to produce stronger results.
FDA-Approved Uses: Who Each One Is Actually For
This is where the four medications diverge most clearly.
Ozempic® is FDA-approved for type 2 diabetes but not specifically approved for obesity, though weight loss is a secondary effect. Wegovy® is FDA-approved for weight management in people with obesity or overweight with related health conditions. Mounjaro® is FDA-approved for type 2 diabetes but not approved for obesity under that brand name. Zepbound™ is approved for weight management and obesity.
In short, Wegovy® and Zepbound™ are the medications specifically cleared for weight loss, while Ozempic® and Mounjaro® are primarily diabetes medications that also produce meaningful weight reduction as an effect of treatment. Your provider will factor your medical history, whether you have type 2 diabetes, and your specific goals into which option makes sense for you.
How Much Weight Can You Expect to Lose?
Results vary by medication, dose, and individual, but clinical trials give us useful benchmarks. Studies have shown that patients taking Ozempic® or Wegovy® can lose up to around 15% of their body weight, while those on Mounjaro® or Zepbound™ may see results of up to 20%.
A head-to-head clinical trial published in the New England Journal of Medicine in 2025 confirmed that tirzepatide-based medications tend to outperform semaglutide-based ones, with patients on Zepbound™ losing an average of about 20% of body weight compared to about 14% for those on Wegovy at 72 weeks.1
It’s worth noting that results depend on factors like starting weight, whether you have type 2 diabetes, dosage, and how well lifestyle habits like diet and exercise are maintained alongside the medication. Your provider will help set realistic expectations based on your individual health profile.
What About Side Effects?
Nausea, vomiting, stomach cramps, bloating, constipation, and diarrhea are the most common side effects, along with fatigue, headaches, and dizziness, and they typically occur when you first start taking the medication or after a dose increase. The good news is that these side effects usually ease over time as your body adjusts. Starting at a lower dose and gradually increasing it is standard practice and helps most people tolerate the medication much better.
Rare but more serious risks include pancreatitis, gallbladder disease, kidney issues related to dehydration, and a potential risk of thyroid tumors in patients with certain genetic conditions. Your provider at Richmond Aesthetic Weight Loss will review your health history carefully before recommending any of these medications.
So Which One Is Right for You?
There’s no universal answer to that question, which is exactly the point. Choosing the right injectable involves weighing your weight loss goals, whether you have diabetes or other metabolic conditions, your insurance coverage, and how your body responds to treatment. Tirzepatide medications like Mounjaro® and Zepbound™ generally produce greater weight loss, but semaglutide options like Ozempic® and Wegovy® have a longer track record and may be the better fit depending on your situation.
At Richmond Aesthetic Weight Loss, we offer these four options because we believe your treatment should be built around you, not a one-size-fits-all approach. Our team takes the time to understand your health history, your goals, and your lifestyle before making a recommendation. The conversation about which injection is right for you starts there.
Ready to take the next step? Contact Richmond Aesthetic Weight Loss today to schedule your consultation and find out which medication fits your path to a healthier weight.
Medical Resources
1Drugs.com: Mounjaro vs Ozempic: Which is right for you?
Previous Post